Interesting websitehttps://www.publicnow.com/view/CB97B737329BCB525A17DCFB22FBADBBDD471D63 Sernova Corp. 09/11/2017 | Press release | Distributed by Public on 09/27/2017 20:04 Sernova Fact Sheet - Sernova Corp. (TSX:V-SVA) is a Canadian-based medical device and combination product development company benefiting patients with chronic metabolic, neurological, and haematological diseases with a first product focus on diabetes, partaking in the near-term $8 billion cell therapy market. Sernova Corp. is a Canadian based health sciences company focused on commercialization of innovative medical technologies. Its lead programs involve The Cell Pouch System, a device for the placement of therapeutic cells which becomes an organ-like structure with microvessels for the nutrition and protection of cells and Sertolin, is a cellular therapy for reversing insulin dependent diabetes through transplanted islet and Sertoli cells. The islet cells naturally produce insulin in response to blood glucose levels while the Sertoli cells provide a natural protection for the islet cells from destruction by the immune system. Sernova has exclusive rights to the patents and associated intellectual property for the therapeutic use of Sertoli cells in the United States, Canada and most major industrialized nations and has patent filings for the Cell Pouch System technology. All content is copyright 2001 - 2017 Sernova Corp.